• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢呋辛在持续非卧床腹膜透析和间歇性腹膜透析中的药代动力学

Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis.

作者信息

Chan M K, Browning A K, Poole C J, Matheson L A, Li C S, Baillod R A, Moorhead J F

出版信息

Nephron. 1985;41(2):161-5. doi: 10.1159/000183573.

DOI:10.1159/000183573
PMID:4047273
Abstract

Pharmacokinetics of cefuroxime was studied in patients on continuous ambulatory or intermittent peritoneal dialysis. A single intravenous bolus (15 mg/kg) of cefuroxime provided a mean serum concentration of 86 mg/litre 5 min, 40 mg/litre 1 h, 163 mg/litre 24 h after the injection. The peritoneal clearance of cefuroxime varied widely among different individuals, ranging from 1.45 to 6.17 ml/min with a mean of 3.59 ml/min during 4-hour exchanges, and from 0,52 to 11.3 ml/min during 2-hour exchanges. A single injection (15 mg/kg) of the antibiotic could not provide satisfactory antibiotic concentrations in peritoneal effluent during peritoneal lavage. When cefuroxime had been added to peritoneal dialysis solution before the solution was instilled into the peritoneal cavity, a significant decrease in cefuroxime concentration occurred in the peritoneal effluent even after a short equilibration time. Furthermore, cefuroxime concentrations measured in residual dialysis solutions in the plastic bags ranged from 44.3 to 1,351% of the concentration of cefuroxime calculated from the added doses, indicating that despite great care, mixing of the antibiotic with dialysis solutions in plastic bags was far from uniform.

摘要

在进行持续非卧床腹膜透析或间歇性腹膜透析的患者中研究了头孢呋辛的药代动力学。静脉注射单次大剂量(15mg/kg)头孢呋辛后,注射后5分钟血清平均浓度为86mg/L,1小时为40mg/L,24小时为163mg/L。头孢呋辛的腹膜清除率在不同个体间差异很大,4小时换液期间为1.45至6.17ml/min,平均为3.59ml/min;2小时换液期间为0.52至11.3ml/min。单次注射(15mg/kg)抗生素在腹膜灌洗期间不能使腹膜流出液中的抗生素浓度达到满意水平。在将腹膜透析液灌入腹腔之前向其中加入头孢呋辛后,即使经过较短的平衡时间,腹膜流出液中的头孢呋辛浓度也会显著降低。此外,塑料袋中残留透析液中测得的头孢呋辛浓度为根据添加剂量计算所得浓度的44.3%至1351%,这表明尽管极为小心,但抗生素与塑料袋中透析液的混合仍远不均匀。

相似文献

1
Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis.头孢呋辛在持续非卧床腹膜透析和间歇性腹膜透析中的药代动力学
Nephron. 1985;41(2):161-5. doi: 10.1159/000183573.
2
The effect of peritonitis on the distribution of cefuroxime in patients undergoing continuous ambulatory peritoneal dialysis.
Scott Med J. 1984 Apr;29(2):117-8. doi: 10.1177/003693308402900213.
3
Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis.头孢呋辛在腹膜透析期间静脉注射和腹腔注射的药代动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):92-4.
4
Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析并发腹膜炎的口服治疗
Clin Nephrol. 1985 May;23(5):241-4.
5
Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis.腹膜透析患者静脉注射和腹腔注射头孢呋辛的药代动力学
Clin Nephrol. 1981 Jul;16(1):40-3.
6
Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Perit Dial Int. 1989;9(4):273-5.
7
The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment.腹膜炎对持续性非卧床腹膜透析(CAPD)治疗患者中头孢呋辛经腹膜转运的影响。
Nephrol Dial Transplant. 1990;5(4):275-81. doi: 10.1093/ndt/5.4.275.
8
Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者发生腹膜炎时腹膜通透性增加。
Eur J Clin Pharmacol. 1985;28(2):187-91. doi: 10.1007/BF00609690.
9
Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.在接受持续性非卧床腹膜透析和持续性循环腹膜透析的终末期肾病患者中,使用大剂量腹腔内氨基糖苷类药物治疗腹膜炎。
Adv Perit Dial. 2000;16:280-4.
10
Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
Nephron. 1984;38(1):57-61. doi: 10.1159/000183279.

引用本文的文献

1
Pharmacokinetics and tissue concentrations of cefuroxime.头孢呋辛的药代动力学和组织浓度
Pharm Weekbl Sci. 1990 Dec 14;12(6A):262-6; discussion 267. doi: 10.1007/BF01967830.